Your browser doesn't support javascript.
loading
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Liang, Winnie S; Vergilio, Jo-Anne; Salhia, Bodour; Huang, Helen J; Oki, Yasuhiro; Garrido-Laguna, Ignacio; Park, Haeseong; Westin, Jason R; Meric-Bernstam, Funda; Fabrizio, David; Miller, Vincent A; Stephens, Philip J; Fanale, Michelle A; Ross, Jeffrey S; Janku, Filip.
Afiliação
  • Liang WS; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, Arizona, USA.
  • Vergilio JA; Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Salhia B; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, Arizona, USA.
  • Huang HJ; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
  • Oki Y; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garrido-Laguna I; Department of Lymphoma and Myeloma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Park H; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Westin JR; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Meric-Bernstam F; Department of Lymphoma and Myeloma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fabrizio D; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Miller VA; Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Stephens PJ; Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Fanale MA; Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
  • Ross JS; Department of Lymphoma and Myeloma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Janku F; Foundation Medicine, Inc., Cambridge, Massachusetts, USA.
Oncologist ; 24(2): 219-228, 2019 02.
Article em En | MEDLINE | ID: mdl-30108156
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Perfilação da Expressão Gênica / Genômica Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Perfilação da Expressão Gênica / Genômica Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos